SAN DIEGO, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the second quarter ended June 30, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, August 10, 2015 at 4:30pm Eastern Time.
| Monday, August 10, 2015 @ 4:30pm Eastern Time/1:30pm Pacific | |
| Toll Free: | 888-523-1228 |
| International: | 719-325-2177 |
| Conference ID: | 9869696 |
| Webcast: | http://edge.media-server.com/m/p/7coqcw2n/lan/en |
| Replays, available through August 24, 2015 | |
| Toll Free: | 877-870-5176 |
| International: | 858-384-5517 |
| Conference ID: | 9869696 |
About Zogenix
Zogenix, Inc. (ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
For more information, visit www.zogenix.com.
CONTACT: Ann Rhoads Chief Financial Officer Zogenix, Inc. 858-436-9208 arhoads@zogenix.com Andrew McDonald Founding Partner LifeSci Advisors, LLC 646-597-6987 Andrew@LifeSciAdvisors.com
Help employers find you! Check out all the jobs and post your resume.
